In addition, a core downstream signaling molecule of the MAPK pathway, NF-κB, a major inflammatory signaling molecule and transcription factor, is activated in the brains of AD patients [62, 63], and is thought to play a key role in AD development and cognitive impairments [64, 65]. Here, NFKB1 is linked to Alzheimer disease.